July 14, 2016—House appropriators are "concerned about the large number of negative comments on" the Health Resources and Service Administration's proposed 340B program omnibus guidance and HRSA's inability "to meet its own deadlines to complete work" on a statutorily mandated secure website to make 340B ceiling prices available to healthcare providers in the drug discount … [Read more...]
GAO Says New Drug Shortages Are Down, but Ongoing Shortages Persist
HHS: depending how one defines shortage, progress might be even greaterJuly 7, 2016—While the number of new drug shortages has generally decreased since 2011, the number of unresolved shortages has remained fairly high, the Government Accountability Office says in a new report. … [Read more...]
Valeant Posts 340B Overcharging Public Notice
Congress has been grilling the company over its massive price hikes on Isuprel and NitropressJuly 5, 2016—Valeant Pharmaceuticals, which is under congressional and Justice Department investigation for its prescription drug pricing, says it might have overcharged healthcare providers in the 340B program for three products between Aug. 4 and Sept. 8, 2015 and will issue the affected providers wholesaler credits. … [Read more...]
Best-selling Drug Prices Far Outpacing Inflation, Even With Discounts
Only six of 39 drugs Bloomberg studied had price increases in line with or below inflationJune 30, 2016—Thirty out of 39 medicines with global sales of more than $1 billion a year had price increases of more than double the rate of inflation from 2009 to 2015, even after estimated discounts were factored in, an analysis by Bloomberg reveals. Only six drugs had price increases in line with or below inflation. … [Read more...]
Hey Big Pharma: Focus on Drug Affordability, Not Hospital Bashing
Pharmaceutical companies should concentrate on making drugs more affordable rather than on disparaging hospitals in the 340B drug discount program, the leader of the association of more than 1,200 hospitals that participate in 340B says in a new op-ed. The drug industry's "tired line of attack regarding 340B hospital charity-care levels…conveniently ignores the $25 billion in … [Read more...]
HRSA Sends 340B Dispute Resolution Rule to OMB for Review
Claims-resolution process would be mandatory and bindingJune 17, 2016—The Health Resources and Services Administration has sent its proposed rule to create a mandatory and binding administrative dispute resolution process for the 340B program to the White House for pre-publication review. … [Read more...]
340B Recertification for Hospitals Tentatively to Begin on Aug. 10
Informational webinar penciled in for July 20June 16, 2016—The Health Resources and Services Administration has started informing hospital groups that annual recertification of eligibility for 340B drug discounts for hospitals is tentatively scheduled to begin Aug. 10 and end Sept. 7, with an informational webinar currently set for July 20. … [Read more...]